---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-022001"
form_type: "8-K"
ticker: "IONS"
cik: "0000874015"
company_name: "IONIS PHARMACEUTICALS INC"
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T16:34:09.629451+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ionis annual meeting: all director nominees elected; equity plan increased by 4M shares

## Summary
- All four director nominees elected: Diaz (134.5M for), Hayden (133.3M), Klein (127.1M), Loscalzo (108.8M).
- Say-on-pay resolution approved with 132.6M votes in favor (95.9% of votes cast).
- Amendment to 2011 Equity Incentive Plan approved; authorized shares increased by 4M to 42.5M.
- Ratification of Ernst & Young as 2025 independent auditors approved with 144.6M votes in favor.

## SEC filing metadata
- accession: 0001140361-25-022001
- form_type: 8-K
- ticker: IONS
- cik: 0000874015
- company_name: IONIS PHARMACEUTICALS INC
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/0001140361-25-022001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/ef20050437_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-022001
- JSON: https://secwatch.observer/filing/0001140361-25-022001.json
- Plain text: https://secwatch.observer/filing/0001140361-25-022001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.